Illuminating pro-opiomelanocortin deficiency

rare-disease-large-blue

Adopting a healthier lifestyle and losing excess weight is a common resolution for the New Year. Some stick to their resolutions and some don’t, but there are also those who can’t. This month, Dr Nicola Davies shines a light on pro-opiomelanocortin (POMC) deficiency.

What is POMC deficiency?

Our brain has circuits devoted entirely to telling us when to start and stop eating. Rarely, people carry mutations in certain genes that regulate the function of these fine neuronal circuits. One of these genes, POMC, encodes for pro-opiomelanocortin, a polypeptide that once produced is further processed to several other biologically active peptides. These peptides are involved in various physiologic processes, including appetite regulation, sexual behavior, adrenal steroidogenesis, and skin pigmentation.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical